Biora Therapeutics (NASDAQ:BIOR – Get Free Report) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, May 15th. Analysts expect the company to announce earnings of ($0.45) per share for the quarter.
Biora Therapeutics (NASDAQ:BIOR – Get Free Report) last released its quarterly earnings results on Tuesday, March 26th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.03). On average, analysts expect Biora Therapeutics to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Biora Therapeutics Stock Performance
Shares of NASDAQ:BIOR opened at $0.74 on Wednesday. The firm has a market cap of $26.57 million, a PE ratio of -0.09 and a beta of 1.22. Biora Therapeutics has a 52 week low of $0.59 and a 52 week high of $6.70. The firm’s fifty day moving average is $0.91 and its 200-day moving average is $1.14.
About Biora Therapeutics
Biora Therapeutics, Inc, a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases.
Read More
- Five stocks we like better than Biora Therapeutics
- What Are Dividends? Buy the Best Dividend Stocks
- How to Read an Earnings Report | Step by Step Guide with Tips
- Trading Stocks: RSI and Why it’s Useful
- Datadog: In the Doghouse or Pullback to the Buyzone?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Celsius Stock’s Post-Earnings Morning Dip, Better than Coffee
Receive News & Ratings for Biora Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biora Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.